MaxCyte (MXCT) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
MaxCyte, Inc. has announced a significant change in its shareholding structure as BlackRock, Inc. reported an increase in its voting rights to 8.75%, up from 9.37%. This adjustment underscores BlackRock’s strategic maneuvers in the financial market, marking its influence in the biopharmaceutical sector.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
